These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 17519642

  • 21. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
    Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD.
    Am J Psychiatry; 2019 Jun 01; 176(6):449-456. PubMed ID: 30654643
    [Abstract] [Full Text] [Related]

  • 22. [Obsessive-compulsive disorder in girls with eating disorders].
    Rabe-Jabłońska J.
    Psychiatr Pol; 1996 Jun 01; 30(2):187-200. PubMed ID: 8650281
    [Abstract] [Full Text] [Related]

  • 23. An open trial of fluoxetine in patients with anorexia nervosa.
    Kaye WH, Weltzin TE, Hsu LK, Bulik CM.
    J Clin Psychiatry; 1991 Nov 01; 52(11):464-71. PubMed ID: 1744064
    [Abstract] [Full Text] [Related]

  • 24. Olanzapine versus placebo for out-patients with anorexia nervosa.
    Attia E, Kaplan AS, Walsh BT, Gershkovich M, Yilmaz Z, Musante D, Wang Y.
    Psychol Med; 2011 Oct 01; 41(10):2177-82. PubMed ID: 21426603
    [Abstract] [Full Text] [Related]

  • 25. Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.
    Ayyıldız H, Turan Ş, Gülcü D, Poyraz CA, Pehlivanoğlu E, Çullu F, Arıkan MK.
    Eat Weight Disord; 2016 Jun 01; 21(2):309-11. PubMed ID: 26607823
    [No Abstract] [Full Text] [Related]

  • 26. Olanzapine in anorexia nervosa.
    Bosanac P, Burrows G, Norman T.
    Aust N Z J Psychiatry; 2003 Aug 01; 37(4):494. PubMed ID: 12873339
    [No Abstract] [Full Text] [Related]

  • 27. The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients.
    Halmi KA.
    Am J Psychiatry; 2008 Oct 01; 165(10):1227-8. PubMed ID: 18829874
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.
    Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P.
    Australas Psychiatry; 2005 Mar 01; 13(1):72-5. PubMed ID: 15777417
    [Abstract] [Full Text] [Related]

  • 34. Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial.
    Zipfel S, Wild B, Groß G, Friederich HC, Teufel M, Schellberg D, Giel KE, de Zwaan M, Dinkel A, Herpertz S, Burgmer M, Löwe B, Tagay S, von Wietersheim J, Zeeck A, Schade-Brittinger C, Schauenburg H, Herzog W, ANTOP study group.
    Lancet; 2014 Jan 11; 383(9912):127-37. PubMed ID: 24131861
    [Abstract] [Full Text] [Related]

  • 35. [Cognitive remediation therapy in adolescent anorexia nervosa--case report].
    Cwojdzińska A, Markowska-Regulska K, Rybakowski F.
    Psychiatr Pol; 2009 Jan 11; 43(1):115-24. PubMed ID: 19694406
    [Abstract] [Full Text] [Related]

  • 36. Does fluoxetine augment the inpatient treatment of anorexia nervosa?
    Attia E, Haiman C, Walsh BT, Flater SR.
    Am J Psychiatry; 1998 Apr 11; 155(4):548-51. PubMed ID: 9546003
    [Abstract] [Full Text] [Related]

  • 37. Body attitudes in patients with eating disorders at presentation and completion of intensive outpatient day treatment.
    Exterkate CC, Vriesendorp PF, de Jong CA.
    Eat Behav; 2009 Jan 11; 10(1):16-21. PubMed ID: 19171312
    [Abstract] [Full Text] [Related]

  • 38. Lifetime substance abuse, family history of alcohol abuse/dependence and novelty seeking in eating disorders: comparison study of eating disorder subgroups.
    Krug I, Pinheiro AP, Bulik C, Jiménez-Murcia S, Granero R, Penelo E, Masuet C, Agüera Z, Fernández-Aranda F.
    Psychiatry Clin Neurosci; 2009 Feb 11; 63(1):82-7. PubMed ID: 19154214
    [Abstract] [Full Text] [Related]

  • 39. Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach.
    Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D.
    Psychoneuroendocrinology; 2001 May 11; 26(4):393-409. PubMed ID: 11259859
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.